A. Moran, D. Becker, and S. J. Casella, Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis-Related Diabetes: A technical review, Diabetes Care, vol.33, issue.12, pp.2677-2683, 2010.

A. Moran, K. Pillay, D. J. Becker, and C. L. Acerini, Management of cystic fibrosis-related diabetes in children and adolescents: Management of cystic fibrosis-related diabetes, Pediatr Diabetes, vol.15, issue.S20, pp.65-76, 2014.

L. Dobson, C. D. Sheldon, and A. T. Hattersley, Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?, J R Soc Med, vol.97, pp.26-35, 2004.

M. Lavie, D. Fisher, and D. Vilozni, Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status, Diabetes Res Clin Pract, vol.110, issue.3, pp.276-284, 2015.

M. Costa, S. Potvin, and I. Hammana, Increased glucose excursion in cystic fibrosis and its association with a worse clinical status, J Cyst Fibros, vol.6, issue.6, pp.376-383, 2007.

E. H. Baker, N. Clark, and A. L. Brennan, Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis, J Appl Physiol, vol.102, issue.5, pp.1969-1975, 2007.

J. P. Garnett, K. K. Kalsi, and M. Sobotta, Hyperglycaemia and Pseudomonas aeruginosa acidify cystic fibrosis airway surface liquid by elevating epithelial monocarboxylate transporter 2 dependent lactate-H+ secretion, Scientific Rep, vol.6, issue.1, 2016.

A. L. Brennan, K. M. Gyi, and D. M. Wood, Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis, J Cyst Fibros, vol.6, issue.2, pp.101-109, 2007.

A. Leclercq, B. Gauthier, and V. Rosner, Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients, J Cyst Fibros, vol.13, issue.4, pp.478-484, 2014.

S. Hameed, A. Jaffé, and C. F. Verge, Advances in the detection and management of cystic fibrosis related diabetes, Curr Opin Pediatr, vol.27, issue.4, pp.525-533, 2015.

K. Schmid, K. Fink, R. W. Holl, H. Hebestreit, and M. Ballmann, Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test, J Cyst Fibros, vol.13, issue.1, pp.80-85, 2014.

A. Coriati, S. Ziai, A. Lavoie, Y. Berthiaume, and R. Rabasa-lhoret, The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis, Acta Diabetologica, vol.53, issue.3, pp.359-366, 2016.

S. Sheikh, M. E. Putt, K. A. Forde, R. C. Rubenstein, and A. Kelly, Elevation of one hour plasma glucose during oral glucose tolerance testing: 1-Hour Plasma Glucose and Cystic Fibrosis, Pediatr Pulmonol, vol.50, issue.10, pp.963-969, 2015.

S. Hameed, J. R. Morton, and P. I. Field, Once daily insulin detemir in cystic fibrosis with insulin deficiency, Arch Dis Child, vol.97, issue.5, pp.464-467, 2012.

L. Dobson, Clinical improvement in cystic fibrosis with early insulin treatment, Arch Dis Child, vol.87, issue.5, pp.430-431, 2002.

A. Moran, P. Pekow, and P. Grover, Insulin Therapy to Improve BMI in Cystic FibrosisRelated Diabetes Without Fasting Hyperglycemia: Results of the Cystic Fibrosis Related Diabetes Therapy Trial, Diabetes Care, vol.32, issue.10, pp.1783-1788, 2009.

A. Moran, C. Brunzell, and R. C. Cohen, Clinical Care Guidelines for Cystic FibrosisRelated Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, vol.33, issue.12, pp.2697-2708, 2010.

M. Pu, F. C. Christensen-adad, A. C. Gonçalves, W. J. Minicucci, J. D. Ribeiro et al., Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review, Revista Paulista de Pediatria, vol.34, issue.3, pp.367-373, 2016.

E. Mozzillo, A. Franzese, and G. Valerio, One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements, Pediatr Diabetes, vol.10, issue.3, pp.162-167, 2009.

S. Kolou?ková, D. Zemková, and J. Barto?ová, Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study, J Pediatr Endocrinol Metabol, vol.24, pp.7-8, 2011.

P. Ciampalini, C. Bizzarri, S. Bella, B. Russo, M. Cappa et al., 51 Effects of glargine insulin in patient with Cystic Fibrosis (CF) and impaired glucose tolerance (IGT), J Cyst Fibros, vol.5, p.12, 2006.

G. Alicandro, P. M. Battezzati, and A. Battezzati, Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance, Clinl Nutr, vol.31, issue.1, pp.118-123, 2012.

J. L. Wooldridge, R. D. Szczesniak, M. C. Fenchel, and D. A. Elder, Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients, J Cyst Fibros, vol.14, issue.6, pp.792-797, 2015.

M. Cano-megías, G. Vasco, P. , G. Albarrán, O. et al., Association of the relative change in weight and body mass index with lung function in teenagers and adults with cystic fibrosis: Influence of gender and diabetes, Endocrinol Nutr, vol.62, issue.9, pp.422-429, 2015.

R. Drummond, E. Ross, S. Bicknell, M. Small, and G. Jones, Insulin therapy in patients with cystic fibrosis related diabetes mellitus: benefit, timing of initiation and hypoglycaemia, Pract Diabetes Intern, vol.28, issue.4, pp.177-182, 2011.

L. Minicucci, M. Haupt, and R. Casciaro, Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial, Pediatr Diabetes, vol.13, issue.2, pp.197-202, 2012.

Q. Reynaud, M. Rabilloud, and S. Roche, Glucose trajectories in cystic fibrosis and their association with pulmonary function, J Cyst Fibros, vol.17, issue.3, pp.400-406, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01829609

A. Moran, K. Pillay, D. Becker, A. Granados, S. Hameed et al., ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents, Pediatr Diabetes, vol.19, pp.64-74, 2018.